BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25738571)

  • 1. Association of VEGFR-2 Gene Polymorphisms With Clopidogrel Resistance in Patients With Coronary Heart Disease.
    Zhang LJ; Zhang YQ; Han X; Zhang ZT; Zhang ZQ
    Am J Ther; 2016; 23(6):e1663-e1670. PubMed ID: 25738571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIK3CG single nucleotide polymorphisms are associated with poor responsiveness to clopidogrel and increased risk of ischemia in patients with coronary heart disease.
    Li KC; Yu SH; Zhuge BZ
    Medicine (Baltimore); 2017 Sep; 96(36):e7566. PubMed ID: 28885323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
    Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R
    Platelets; 2013; 24(4):297-302. PubMed ID: 22721490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.
    Zhang D; Zhang X; Liu D; Liu T; Cai W; Yan C; Han Y
    Cardiovasc Diabetol; 2016 Mar; 15():50. PubMed ID: 27005817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of P2Y12R gene polymorphisms with susceptibility to coronary heart disease and clinical efficacy of antiplatelet treatment with clopidogrel.
    Yang HH; Chen Y; Gao CY
    Cardiovasc Ther; 2016 Dec; 34(6):460-467. PubMed ID: 27566695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between clopidogrel resistance and polymorphism of platelet adenosine diphosphate receptor in patients with coronary atherosclerotic disease].
    Li XJ; Chen XM
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 May; 43(3):333-8. PubMed ID: 24998658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans.
    Lee JM; Park S; Shin DJ; Choi D; Shim CY; Ko YG; Kim JS; Shin ES; Chang CW; Lee JE; Jang Y
    Am J Cardiol; 2009 Jul; 104(1):46-51. PubMed ID: 19576320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease.
    Liu D; Song J; Ji X; Liu Z; Cong M; Hu B
    Medicine (Baltimore); 2016 May; 95(19):e3413. PubMed ID: 27175642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2RY12 gene polymorphisms and effect of clopidogrel on platelet aggregation.
    Galić E; Vrbanić L; Kapitanović S; Catela Ivković T; Petro D; Vuković I; Bsharat RS; Milicević Z; Vcev A; Mirat J
    Coll Antropol; 2013 Jun; 37(2):491-8. PubMed ID: 23940995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention.
    Liu T; Yin T; Li Y; Song LQ; Yu J; Si R; Zhang YM; He Y; Guo WY; Wang HC
    Coron Artery Dis; 2014 Aug; 25(5):412-20. PubMed ID: 24608794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of cytochrome P450 2C19 genetic polymorphism on clopidogrel resistance and recent prognosis of patients with acute coronary syndrome].
    Li SN; Liu Z; Luo Y; Chen PA; Lei XM; Li GL
    Zhonghua Nei Ke Za Zhi; 2013 Nov; 52(11):961-5. PubMed ID: 24439192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
    Thromb Res; 2005; 116(6):491-7. PubMed ID: 16181985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PXR polymorphisms have impact on the clinical efficacy of clopidogrel in patients undergoing percutaneous coronary intervention.
    Wu Y; Yu H; Tang HQ; Su Y; Shi TL; Liu S; Xia Q; Xu DJ
    Gene; 2018 May; 653():22-28. PubMed ID: 29432831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects.
    Mao L; Jian C; Changzhi L; Dan H; Suihua H; Wenyi T; Wei W
    Arch Cardiovasc Dis; 2013 Oct; 106(10):517-27. PubMed ID: 24080325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI.
    Rath PC; Chidambaram S; Rath P; Dikshit B; Naik S; Sahoo PK; Das B; Mahalingam M; Khandrika L; Jain J
    Indian Heart J; 2015; 67(2):114-21. PubMed ID: 26071289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease.
    Li L; Pan Y; Dai L; Liu B; Zhang D
    Med Sci Monit; 2016 Jan; 22():31-40. PubMed ID: 26726843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efffect of the ABCC3 -211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention.
    Zou JJ; Fan HW; Chen SL; Tan J; He BS; Xie HG
    Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):504-9. PubMed ID: 23692149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C19 polymorphisms in acute coronary syndrome patients undergoing clopidogrel therapy in Zhengzhou population.
    Guo YM; Zhao ZC; Zhang L; Li HZ; Li Z; Sun HL
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the proton pump inhibitors and CYP2C19*2 polymorphism on platelet response to clopidogrel as assessed by four platelet function assays.
    Tsantes AE; Ikonomidis I; Papadakis I; Bonovas S; Gialeraki A; Kottaridi C; Kyriakou E; Kokori S; Douramani P; Kopterides P; Karakitsos P; Lekakis J; Kapsimali V
    Thromb Res; 2013 Aug; 132(2):e105-11. PubMed ID: 23830212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.